We ahve been informed about the subcutan administration of immunoglobulins with the use of hyalorunidase. This troute of administration is attractive for our patients who have difficult venous access. Conceerns are possible infections at the site of injection, something which we will evaluate.
Presenter: Medical personel of the distributing company,
Participants: all medical staff